Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro

Acta Physiologica Sinica

Volumn 55, Issue 2, 2003, Pages 187-190

  Yu, Jun ^a   Zhu, Miao Zhang ^a   Wei, Geng Ze ^a   Chen, Bao Ying ^b   Lu, Shun Yan ^a   Kang, Yun Fan ^c   Guo, Hai Tao ^a   Ma, Heng ^a   Dong, Ming Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CGMP; Human intramammary artery; Methylene blue; TEA; Vasonatrin peptide

Indexed keywords

8 BROMO CYCLIC GMP; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; HS 142 1; METHYLENE BLUE; NORADRENALIN; PEPTIDE; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VASONATRIN;

ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; ENDOTHELIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAMMARY ARTERY; PROTEIN BINDING; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

AGED; ATRIAL NATRIURETIC FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAMMARY ARTERIES; MIDDLE AGED; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RECEPTORS, GUANYLATE CYCLASE-COUPLED; VASODILATION;

EID: 0038813809     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Feng HS, Zang YM, Zhu MZ, Pei JM, Wang YM, Niu GB, Wang L, Shi PT. Vasorelaxing effect of vasonatrin peptide on pulmonary artery in rats. Chin J Cardiac Func 1998; 10: 69-71 (Chinese, English abstract).
2. Feng HS, Zang YM, Zhu MZ, Wang YM, Wang L, Shi PT. The vasorelaxing effect of vasonatrin peptide on isolated vascular strips in chronic hypoxic rats. J Fourth Mil Med Univ 1998; 19: 398-400 (Chinese, English abstract).
3. Feng HS, Zang YM, Zhu MZ, Wang YM, Wang L, Shi PT. Comparison of inhibitory effects of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide on pulmonary artery hypertension induced by chronic hypoxia in rats. Chin J Tuber Respir Dis 2000; 23: 427-428 (Chinese, English abstract).
4. Feng HS, Zang YM, Zhu MZ, Pei JM, Wang YM, Wang L, Shi PT. Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide. Acta Physiol Sin 1999; 51(5): 515-520 (Chinese, English abstract).
5. Wei CM, Kim CH, Khraibi AA, Miller VM, Burnett JC Jr. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension 1994; 23 (6 Pt 2): 903-907.
6. Wei CM, Kim CH, Miller VM, Burnett JC Jr. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Inves 1993; 92: 2048-2052.
7. Cao L, Zlock DW, Gardner DG. Differential regulation of natriuretic peptide receptor activity in vascular cells. Hypertension 1994; 24: 329-338.
8. Dong MQ, Zhu MZ, Yu J, Shang LJ, Feng HS. Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats. Acta Physiol Sin 2000; 52(3): 252-254 (Chinese, English abstract).
9. Lu SY, Zhu MZ, Guo HT, Yu J, Wei QM. Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes. Acta Physiol Sin 2002; 54(1): 711 (Chinese, English abstract).
10. i of cultured rat cardiac fibroblasts. Acta Physiol Sin 2001; 53(4): 286 -290 (Chinese, English abstract).
11. Lincoln TM, Dey N, Sellak H. cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 2001; 91: 1421-1430.